Ticker Sage

Form 4 · ABBV

AbbVie EVP Azita Saleki reports exercising or converting 23,935 shares

Part of a grouped insider digest: see all related filings with totals →

Azita Saleki, AbbVie's EVP, CHIEF OPERATIONS OFFICER, filed a Form 4 on Nov 18, 2026 at 5:00 PM ET reporting transactions on Nov 16, 2026.

The filing reports 23,935 shares in an exercise or conversion of a derivative security (code M); and 13,481 shares withheld to pay the exercise price or tax (code F).

After these transactions, the filing lists 208,248 shares of Common Stock, $0.01 par value held directly.

Effect on holdings

Taken together, the rows reported here raised Azita Saleki's directly held shares by 5.3%, from 197,794 to 208,248.

Reporting person

Transactions as reported

DateCodeSecuritySharesPriceAcquired or disposedHeld afterOwnership
2026-11-16MCommon Stock, $0.01 par value23,935$61.36Acquired221,729Direct
2026-11-16FCommon Stock, $0.01 par value13,481$298.55Disposed208,248Direct
2026-11-16MOption (Right to Buy) (derivative)13,481Disposed23,935Direct

Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.

Source

AbbVie company file → · More AbbVie filings

The filings digest

A free email of market-moving SEC filings. Daily on weekdays, or one weekly edition.

We will email a confirmation link. Unsubscribe any time. See Privacy.

Disclosures

Editor holdings in ABBV
The editor holds no position in AbbVie (ABBV). As of Nov 11, 2026.
Last updated
Nov 18, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.